Table 1.
Characteristic | Baseline (N=51)N (%) |
---|---|
Demographics | |
Age (y), mean±SD | 71.1±8.3 |
Men | 38 (74.5%) |
White Race | 41 (80.4%) |
Religion | |
Christian | 33 (64.7%) |
Jewish | 6 (11.8%) |
Other | 12 (23.5%) |
Cardiac conditions | |
Coronary artery disease | 32 (62.7%) |
Congestive heart failure | 42 (82.4%) |
New York Heart Association Class | |
I | 23 (45.1%) |
II | 14 (27.5%) |
III | 13 (25.5%) |
IV | 1 (2.0%) |
Atrial fibrillation | 22 (43.1%) |
History of sustained ventricular tachycardia/fibrillation | 21 (41.2%) |
Noncardiac conditions | |
Diabetes mellitus | 23 (45.1%) |
Chronic obstructive lung disease | 8 (15.7%) |
History of malignancy | 1 (2.0%) |
Chronic kidney disease | 47 (92.2%) |
Diagnostic studies | |
Left ventricular ejection fraction (%), mean±SD | 30.0±13.1 |
Glomerular filtration rate (mL/min), mean±SD | 44.4±17.2 |
Device history | |
Duration of implant (y), mean±SD | 5.5±4.4 |
Cardiac resynchronization therapy | 12 (23.5%) |
Primary prevention implant | 37 (72.5%) |
Appropriate implantable cardioverter‐defibrillator therapies prior to enrollment | 15 (29.4%) |
Implantable cardioverter‐defibrillator generator replaced prior to enrollment | 23 (45.1%) |